METHOD FOR TREATMENT OF CENTRAL ATHEROSCLEROTIC CHORIORETINOPATHY Russian patent published in 2006 - IPC A61K31/722 A61K31/727 A61K31/728 A61K31/737 A61K38/18 A61P27/02 

FIELD: medicine, ophthalmology.

SUBSTANCE: method involves a single administration of 1.0 ml of 2% combined hydrogel solution of chitosan ascorbate with deacetylation degree 94-98% and molecular mass 100-700 kDa into Tenon's space wherein this solution comprises 200 mg of hyaluronic acid, 2 g of chondroitinsulfuric acid, 110-440 mcg of cattle serum factor and 50 mg of heparin in 1 l of the solution. Method provides revascularization of the eye posterior pole based on resorption and substitution of hydrogen by the own connective tissue enriched with newly formed vessels of capillary type and activation of perivasal chorioepiscleral anastomosis. Invention can be used in treatment of the central atherosclerotic chorioretinopathy.

EFFECT: improved method of treatment.

1 tbl, 1 ex